Review: taking Neurontin and Hiprex together


Summary

Drug interactions are reported among people who take Neurontin and Hiprex together. This review analyzes the effectiveness and drug interactions between Neurontin and Hiprex. It is created by eHealthMe based on reports of 107 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 76,477 users)

Hiprex

Hiprex has active ingredients of methenamine hippurate. It is often used in urinary tract infection. (latest outcomes from Hiprex 315 users)

On Sep, 26, 2016

107 people who take Neurontin, Hiprex are studied.


Number of reports submitted per year:

Neurontin and Hiprex drug interactions.

Drug effectiveness over time:

Neurontin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Hiprex:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Neurontin:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)
Hiprex:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Hiprex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • autoimmune neuropathy
  • fatigue
  • insomnia
  • prescribed overdose
5 - 10 years:
  • memory impairment
  • muscle fatigue
not specified:
  • drug ineffective
  • headache
  • pain
  • asthenia
  • decreased appetite
  • dyspnoea
  • fall
  • urinary tract infection
  • somnolence
  • nausea

Most common drug interactions by gender *:

female:
  • fall
  • somnolence
  • nausea
  • urinary tract infection
  • drug ineffective
  • dyspnoea
  • headache
  • pain
  • decreased appetite
  • vomiting
male:
  • asthenia
  • urinary tract infection
  • drug ineffective
  • fatigue
  • herpes zoster
  • multiple sclerosis relapse
  • anxiety
  • blood creatine phosphokinase increased
  • blood creatinine increased
  • blood urine present

Most common drug interactions by age *:

20-29:
  • foetal malpresentation
  • maternal exposure during pregnancy
  • prolonged labour
30-39:
  • femur fracture
  • anxiety
  • asthenia
  • bronchitis
  • disease recurrence
  • klebsiella infection
  • memory impairment
  • multiple sclerosis relapse
  • muscle fatigue
  • panic attack
40-49:
  • anxiety
  • clostridium difficile colitis
  • feeling abnormal
  • feeling hot
  • flushing
  • gait disturbance
  • headache
  • malaise
  • multiple sclerosis relapse
  • pneumonia aspiration
50-59:
  • urinary tract infection
  • alopecia
  • fall
  • decreased appetite
  • headache
  • multiple sclerosis relapse
  • nausea
  • suicide attempt
  • abdominal pain
  • abdominal rigidity
60+:
  • fall
  • somnolence
  • nausea
  • dyspnoea
  • pain
  • urinary tract infection
  • vomiting
  • muscular weakness
  • decreased appetite
  • drug ineffective

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Neurontin and Hiprex?

Can you answer these questions?

More questions for: Neurontin, Hiprex

You may be interested in these reviews

More reviews for: Neurontin, Hiprex

On eHealthMe, Neurontin (gabapentin) is often used to treat pain. Hiprex (methenamine hippurate) is often used to treat urinary tract infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.